Mercer Global Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Mercer Global Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3K	Buy	+104	New	+$11.3K	﹤0.01%	5050

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Mercer Global Advisors's PJP Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 104 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #5050 among its holdings.

95 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Mercer Global Advisors held 104 shares of Invesco Pharmaceuticals ETF worth $12.3K as of Q2 2026.
Invesco Pharmaceuticals ETF was a new Mercer Global Advisors position in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5050 holding.
95 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.